An Act relative to pharmaceutical access, costs and transparency
Senate, December 27, 2024 -- Report of the committee of conference on the disagreeing votes of the two branches with reference to the House amendment to the Senate relative to pharmaceutical access, costs and transparency (Senate, No. 2520) (amended by the House all after the enacting clause and inserting in place thereof the text of House document numbered 4910; and by striking out the title and inserting in place thereof the following title: “An Act promoting access and affordability of prescription drugs.”),-- reports, a “Bill relative to pharmaceutical access, costs and transparency” (Senate, No. 3012).
Bill Information
Bill Information
- Sponsor:
- Pharmaceutical access, cost and transparency
Bill History
Date | Branch | Action |
---|---|---|
12/27/2024 | Senate | Reported from a committee of conference |
12/30/2024 | Senate | Reported on S2520 |
12/30/2024 | Senate | Rules suspended |
12/30/2024 | Senate | Committee of conference report accepted |
12/30/2024 | House | Referred to the committee on House Steering, Policy and Scheduling |
12/30/2024 | House | Committee reported that the matter be placed in the Orders of the Day for the next sitting, the question being on acceptance |
12/30/2024 | House | Rules suspended |
12/30/2024 | House | Committee of conference report accepted, in concurrence |
12/30/2024 | House | Motion to reconsider negatived |
12/30/2024 | House | Enacted |
12/30/2024 | House | Motion to reconsider negatived |
12/30/2024 | Senate | Enacted and laid before the Governor |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.